文献速递妇产影像儿科影像US

双绒毛膜双胎的生长能否用个体化生长评估进行监测

Can growth in dichorionic twins be monitored with individualized growth assessment?
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

本研究为ESPRiT研究的二次分析,纳入143例双绒毛膜双胎妊娠的286个胎儿/新生儿,按出生体重分为适龄胎龄儿(AGA,n=243)和小于胎龄儿(SGA,n=43)队列,采用个体化生长评估(IGA)方法。结果显示双胎与单胎在孕中期生长速度差异小且无统计学意义,孕晚期95.7%(1677/1752)的时间点偏离在单胎95%参考范围内,-FGPS1可检测、量化和分类双胎生长病理,但胎儿生长异常与不良新生儿结局的关系证据有限。

要点

  • 双绒毛膜双胎可视为同一子宫内的两个单胎,正常生长的双胎与正常生长结局的单胎具有相同的生长潜力。
  • -FGPS1可在双胎中检测、量化和分类孕晚期生长病理,其模式对97.5%的病理双胎病例进行了分类。
  • 在进展型生长受限双胎中,仅3例(12.5%)出现与生长异常相关的不良新生儿结局,且均为-FGPS1值比-2.0%更负的病例。

核心结论

  • 就生长而言,双绒毛膜双胎可视为同一子宫内的两个单胎,正常生长的双胎具有与正常生长结局单胎相同的生长潜力,并同样精确地遵循预期的孕晚期生长轨迹,-FGPS1可如单胎一样检测、量化和分类孕晚期生长病理,但胎儿生长异常与不良新生儿结局关系的证据有限。

研究设计与样本

  • 本研究为ESPRiT(评估双胎生长受限的超声预测因子)研究的二次分析,纳入143例双绒毛膜双胎妊娠的286个胎儿/新生儿,按出生体重分为AGA队列(n=243)和SGA队列(n=43),采用每2周一次的系列生物测量(双顶径、头围、腹围、股骨干长和估计体重)评估胎儿生长,以出生体重、冠跟长和头围确定新生儿生长结局,评估6种不良新生儿结局(缺氧缺血性脑病、脑室周围白质软化、坏死性小肠结肠炎、呼吸窘迫、败血症和死亡)。

诊断标准与关键数值

  • IGA用于以下方面:比较单胎(来自已发表数据集)与双绒毛膜双胎(138例孕晚期生长正常的AGA双胎)的孕中期生长速度差异;描述双胎孕晚期实际生长遵循预期生长的程度(111例胎儿生长和新生儿生长结局均正常的AGA双胎);确定胎儿生长病理评分1(-FGPS1)能否检测、量化和分类双胎生长病理(224例AGA、42例SGA);评估-FGPS1与不良新生儿结局的关系(24例经异常新生儿生长结局证实为进展型生长受限的SGA双胎)。

临床应用与阅片要点

  • 在正常生长的双绒毛膜双胎中,孕中期生长速度与单胎的差异小且无统计学意义,孕晚期偏离预期 size 轨迹的百分比在95.7%(1677/1752)的时间点位于单胎95%参考范围内;异常生长在37.9%的AGA双胎和85.7%的SGA双胎中检出;AGA双胎的生长受限更具异质性,而SGA双胎以进展型生长受限为主要类型(66.7%);-FGPS1模式对97.5%的病理双胎病例进行了分类;在最严重形式(进展型)中,仅3例(12.5%)出现与生长异常相关的不良新生儿结局,均为-FGPS1值比-2.0%更负的病例,使用这些标准时不良新生儿结局频率为33%。

局限性

  • 原文报告胎儿生长异常与不良新生儿结局之间关系的证据有限。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To characterize fetal growth in dichorionic twins using individualized growth assessment (IGA), a method based on individual growth potential estimates.

METHODS: This secondary analysis included 286 fetuses/neonates from 143 dichorionic twin pregnancies that were part of the ESPRiT (Evaluation of Sonographic Predictors of Restricted Growth in Twins) study. The sample was subcategorized according to birth weight into appropriate-for-gestational-age (AGA) (n = 243) and small-for-gestational-age (SGA) (n = 43) cohorts. Serial biometric scans evaluating biparietal diameter, head circumference (HC), abdominal circumference, femur diaphysis length and estimated weight at 2-week intervals were used to evaluate fetal growth, while measurements of birth weight, crown-heel length and HC determined neonatal growth outcome. Six abnormalities (hypoxic ischemic encephalopathy, periventricular leukomalacia, necrotizing enterocolitis, respiratory distress, sepsis and death) constituted the evaluated adverse neonatal outcomes (ANO). IGA was used to: evaluate differences in second-trimester growth velocities between singletons (from a published dataset) and dichorionic twins (138 AGA twins with normal third-trimester growth); describe the degree to which actual third-trimester growth in twins followed expected growth (111 AGA twins, normal fetal growth and neonatal growth outcomes); determine if the fetal growth pathology score 1 (-FGPS1) could detect, quantify and classify twin growth pathology (224 AGA, 42 SGA); and assess the relationship between -FGPS1 and ANO (24 SGA twins with progressive growth restriction confirmed by abnormal neonatal growth outcome).

RESULTS: The differences in second-trimester growth velocity between singletons and twins (means and variances) were small and not statistically significant. Percent deviations from the expected third-trimester size trajectories were within the 95% reference ranges derived from singletons at 95.7% (1677/1752) of timepoints studied. Abnormal growth was detected in 37.9% of AGA twins and 85.7% of SGA twins. Growth restriction was more heterogeneous in AGA twins, while in SGA twins progressive growth restriction was the principal type (66.7%). -FGPS1 patterns previously defined in singletons classified 97.5% of pathological twin cases. In our most severe form of growth restriction (progressive), there were only three (12.5%) ANOs related to growth abnormalities, all in cases with -FGPS1 values more negative than -2.0%. Using these criteria, the frequency of ANO was 33%.

CONCLUSIONS: With respect to growth, dichorionic twins can be considered as two singletons in the same uterus. Normally growing dichorionic twins have the same growth potential as singletons with normal growth outcome. These twins also follow expected third-trimester growth trajectories with the same precision as do singletons. Third-trimester growth pathology can be detected, quantified and classified using -FGPS1 as in singletons. Limited evidence of a relationship between fetal growth abnormalities and adverse neonatal outcome was found. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Deter RL, Lee W, Dicker P, et al. Can growth in dichorionic twins be monitored with individualized growth assessment? Ultrasound Obstet Gynecol. 2023. PMID: 37488689. doi:10.1002/uog.26320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。